Investment in "health sciences" grows by 1001Tbp1T in Q2 2013

, ,
Integral service around a transaction
BY : Diego GutiérrezOctober Wed, 2013

venture capital, financingAccording to a report by Clipperton finance, the health sciences sector experienced solid growth (100%) in Q2 2013 over the previous quarter with several large deals (>$50M) in "Medtech" and "Biotech".


The health sector accounts for 29% of the total amount invested.

The healthcare sector attracted a significant share of the pie in the second quarter of the year with a growth of 100% with $453M. The IT sector topped the ranking with 62% representing a decrease of 5%. The cleantech sector reached the same level as the previous quarter with 9%.

"In Spain, the sector has also accounted for a similar percentage as investments of Venture capital. In the second quarter there were 26 transactions with €11m of investment. Significant was the sale of Endosense owned by Ysios. A significant round is expected to take place in the coming months. TCD Pharma"Diego Gutierrez, an expert in corporate finance, points out in ABRA INVEST.

Most relevant operations

The largest operation has been carried out by Auris Medical  $51M. The round was participated by Sofinnova partners and Sofinnova Ventures. The company will devote the investment to the development of its hearing loss drugs.

In second place comes the operation carried out in Opsona Therapeutics of $43M financed by BB BiotechSunstone, Baxter, Amgen and EMBL Ventures. The company focuses on inflammatory anti-immune diseases.

"In the USA, investment in the sector has accelerated, especially in companies oriented towards the reduction of waste. health costs and optimisation of resources, due to the Affordable Care Act, with which Obama intends to universalise healthcare. 47% of these investments in 2012 went to seed-stage companies," analyses Diego Gutierrez.

The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?